Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals-Reference-Cited by-同舟云学术

Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals

Published:2018-02-06 Issue:6 Volume:25 Page:707-717
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Cho H.¹,Ahn H.¹,Lee D. H.¹²,Lee J.-H.¹^ORCID,Jung Y. J.²,Chang Y.¹,Nam J. Y.¹,Cho Y. Y.¹,Lee D. H.³,Cho E. J.¹,Yu S. J.¹,Lee J. M.³,Kim Y. J.¹^ORCID,Yoon J.-H.¹

Affiliation:

1. Department of Internal Medicine and Liver Research Institute; Seoul National University College of Medicine; Seoul Korea

2. Department of Internal Medicine; Seoul Metropolitan Government Seoul National University Boramae Medical Center; Seoul Korea

3. Department of Radiology; Seoul National University College of Medicine; Seoul Korea

Funder

National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea

Liver Research Foundation of Korea as part of Bio Future Strategies Research Project

Seoul National University Hospital

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12855/fullpdf

Reference56 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis;Poon;J Clin Oncol,2000

3. A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution;Toyama;J Clin Gastroenterol,2008

4. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre;Grazi;Aliment Pharmacol Ther,2003

5. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma;Wu;J Hepatol,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma;BMC Cancer;2024-03-04

2. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies;Asian Journal of Surgery;2024-01

3. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy;Journal of Hepatocellular Carcinoma;2023-11

4. Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection;JAMA Network Open;2023-10-31

5. Entecavir versus tenofovir on the recurrence of hepatitis B–related HCC after liver transplantation: A multicenter observational study;Liver Transplantation;2023-07-26